Principal Financial Group
ARQT icon

Principal Financial Group’s Arcutis Biotherapeutics ARQT Stock Holding History

Principal Financial Group’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.98M Buy
+168,826
New +$4.31M ﹤0.01% 1687
2024
Q3 		– Sell
-18,555
Closed -$173K – 2238
2024
Q2 		$173K Sell
18,555
-570
-3% -$5.16K ﹤0.01% 2163
2024
Q1 		$190K Buy
19,125
+705
+4% +$5.26K ﹤0.01% 2186
2023
Q4 		$59.5K Buy
18,420
+3,336
+22% +$9.07K ﹤0.01% 2317
2023
Q3 		$80.1K Buy
15,084
+148
+1% +$1.26K ﹤0.01% 2312
2023
Q2 		$142K Buy
14,936
+1,553
+12% +$17.2K ﹤0.01% 2233
2023
Q1 		$147K Sell
13,383
-979
-7% -$14.2K ﹤0.01% 2233
2022
Q4 		$213K Buy
14,362
+2,654
+23% +$46.4K ﹤0.01% 2179
2022
Q3 		$223K Buy
11,708
+621
+6% +$14.1K ﹤0.01% 2176
2022
Q2 		$236K Buy
+11,087
New +$227K ﹤0.01% 2249
2021
Q4 		– Sell
-9,951
Closed -$238K – 2536
2021
Q3 		$238K Sell
9,951
-1,611
-14% -$36.7K ﹤0.01% 2382
2021
Q2 		$316K Buy
+11,562
New +$326K ﹤0.01% 2339

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return